OBJECTIVE: To investigate mortality rates and risk factors for death among smear-negative tuberculosis (TB) suspects. DESIGN: Cohort study nested within a cluster-randomised trial of community-based active case finding. Smear-negative TB suspects were followed for 12 months, with home tracing where necessary. We calculated mortality rates and used regression analysis to investigate the relationship between clinical characteristics and death. RESULTS: Between February 2006 and June 2007, 1195 smear-negative TB suspects were followed for 1136.8 person-years. Human immunodeficiency virus (HIV) prevalence was 63.3%. During follow-up, 139 participants died (11.6%) and mortality rates remained high throughout; 119 (16.5%) HIV-positive individuals and 13 (3.1%) HIV-negative individuals died (HR = 5.8, 95%CI 3.3-10.4, P < 0.001). Advanced immunosuppression was the main risk factor for death among HIV-positive participants, with CD4 count < 50 cells/μ l associated with a 13-fold increased risk of death. Antiretroviral treatment (ART) was initiated by only 106 (14.7%), with long delays in accessing care. CONCLUSION: HIV-positive smear-negative TB suspects are at high and sustained risk of death. Current guidelines for the management of HIV-infected TB suspects are limited, and this study adds to evidence that specific policies are required to promote earlier HIV and TB diagnosis and reduce delays in ART initiation.
OBJECTIVE: To investigate mortality rates and risk factors for death among smear-negative tuberculosis (TB) suspects. DESIGN: Cohort study nested within a cluster-randomised trial of community-based active case finding. Smear-negative TB suspects were followed for 12 months, with home tracing where necessary. We calculated mortality rates and used regression analysis to investigate the relationship between clinical characteristics and death. RESULTS: Between February 2006 and June 2007, 1195 smear-negative TB suspects were followed for 1136.8 person-years. Human immunodeficiency virus (HIV) prevalence was 63.3%. During follow-up, 139 participants died (11.6%) and mortality rates remained high throughout; 119 (16.5%) HIV-positive individuals and 13 (3.1%) HIV-negative individuals died (HR = 5.8, 95%CI 3.3-10.4, P < 0.001). Advanced immunosuppression was the main risk factor for death among HIV-positive participants, with CD4 count < 50 cells/μ l associated with a 13-fold increased risk of death. Antiretroviral treatment (ART) was initiated by only 106 (14.7%), with long delays in accessing care. CONCLUSION: HIV-positive smear-negative TB suspects are at high and sustained risk of death. Current guidelines for the management of HIV-infected TB suspects are limited, and this study adds to evidence that specific policies are required to promote earlier HIV and TB diagnosis and reduce delays in ART initiation.
Authors: Anthony D Harries; Rony Zachariah; Elizabeth L Corbett; Stephen D Lawn; Ezio T Santos-Filho; Rhehab Chimzizi; Mark Harrington; Dermot Maher; Brian G Williams; Kevin M De Cock Journal: Lancet Date: 2010-05-18 Impact factor: 79.321
Authors: Kevin P Cain; Kimberly D McCarthy; Charles M Heilig; Patama Monkongdee; Theerawit Tasaneeyapan; Nong Kanara; Michael E Kimerling; Phalkun Chheng; Sopheak Thai; Borann Sar; Praphan Phanuphak; Nipat Teeratakulpisarn; Nittaya Phanuphak; Huy Dung Nguyen; Thi Quy Hoang; Hung Thai Le; Jay K Varma Journal: N Engl J Med Date: 2010-02-25 Impact factor: 91.245
Authors: Munyaradzi Dimairo; Peter MacPherson; Tsitsi Bandason; Abbas Zezai; Shungu S Munyati; Anthony E Butterworth; Stanley Mungofa; Simba Rusikaniko; Katherine Fielding; Peter R Mason; Elizabeth L Corbett Journal: PLoS One Date: 2010-07-28 Impact factor: 3.240
Authors: E Botha; S den Boon; K-A Lawrence; H Reuter; S Verver; C J Lombard; C Dye; D A Enarson; N Beyers Journal: Int J Tuberc Lung Dis Date: 2008-08 Impact factor: 2.373
Authors: David Moore; Cheryl Liechty; Paul Ekwaru; Willy Were; Gerald Mwima; Peter Solberg; George Rutherford; Jonathan Mermin Journal: AIDS Date: 2007-03-30 Impact factor: 4.177
Authors: C Palanivel; A M V Kumar; T Mahalakshmi; S Govindarajan; M Claassens; S Satyanarayana; D Gurumurthy; K Vasudevan; A Purty; A K Paulraj; K V Raman Journal: Public Health Action Date: 2013-09-21
Authors: Yanjia J Zhang; Manchi C Reddy; Thomas R Ioerger; Alissa C Rothchild; Veronique Dartois; Brian M Schuster; Andrej Trauner; Deeann Wallis; Stacy Galaviz; Curtis Huttenhower; James C Sacchettini; Samuel M Behar; Eric J Rubin Journal: Cell Date: 2013-12-05 Impact factor: 41.582
Authors: A Van Rie; L Page-Shipp; C F Hanrahan; K Schnippel; H Dansey; J Bassett; K Clouse; L Scott; W Stevens; I Sanne Journal: Int J Tuberc Lung Dis Date: 2013-03 Impact factor: 2.373
Authors: Peter MacPherson; Rein M G J Houben; Judith R Glynn; Elizabeth L Corbett; Katharina Kranzer Journal: Bull World Health Organ Date: 2013-11-22 Impact factor: 9.408
Authors: Andrew R DiNardo; Alexander W Kay; Gugu Maphalala; Nadine M Harris; Celia Fung; Godwin Mtetwa; Pilar Ustero; Sindisiwe Dlamini; Ngan Ha; Edward A Graviss; Rojelio Mejia; Anna M Mandalakas Journal: Am J Trop Med Hyg Date: 2018-04-19 Impact factor: 2.345